Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webb, P. G.
Right arrow Articles by Bonser, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webb, P. G.
Right arrow Articles by Bonser, A. M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 4, Issue 6 616-619, Copyright © 1981 by American Diabetes Association

ARTICLES

Basal C-peptide in the discrimination of type I from type II diabetes

PG Webb and AM Bonser

Basal serum C-peptide concentrations in diabetic patients showed two groups. Diabetic patients with low C-peptide levels (less than or equal to 0.16 nmol/L) have clinical characteristics of type I diabetes, and all were on insulin therapy. With long duration of diabetes, an increasing proportion had undetectable C-peptide. Diabetic patients with high C-peptide levels (greater than 0.16 nmol/L) resemble type II diabetes. In this group 30% were on insulin therapy but duration of known disease was not associated with any decline in the high basal C-peptide levels. The small proportion of diabetic patients with basal serum C-peptide in the range of 0.17-0.32 nmol/L have indeterminate status.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
L. Azadbakht, M. Kimiagar, Y. Mehrabi, A. Esmaillzadeh, M. Padyab, F. B Hu, and W. C Willett
Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 735 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. J. Tapp, J. E. Shaw, C. A. Harper, M. P. de Courten, B. Balkau, D. J. McCarty, H. R. Taylor, T. A. Welborn, and P. Z. Zimmet
The Prevalence of and Factors Associated With Diabetic Retinopathy in the Australian Population
Diabetes Care, June 1, 2003; 26(6): 1731 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. S Siraj, S. S. K Reddy, W. A Scherbaum, J. Abdulkadir, J. P Hammel, and C. Faiman
Basal and Postglucagon C-Peptide Levels in Ethiopians with Diabetes
Diabetes Care, March 1, 2002; 25(3): 453 - 457.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1981 by the American Diabetes Association.